TMO continues to capture investors' attention due to its innovative product launches and trusted partnership status.

Investors focused on top-and-bottom-line performance—important as they are—do so at the risk of neglecting another crucial ...

Single-use technologies in biopharmaceuticals are disposable tools that improve efficiency, reduce contamination, and cut costs. They are becoming popular for producing medicines like vaccines and ...

Roche plans to release the system in the US to run tests including vitamin D and steroid assays under CLIA before it possibly receives US Food and Drug Administration clearance.

The global gene transfer technologies market, valued at US$3.63 billion in 2023, is forecasted to grow at a robust CAGR of 9.7%, reaching US$3.73 ...

The global vaccine storage equipment market, valued at US$0.82 billion in 2023, is forecasted to grow at a robust CAGR of 7.2%, reaching US$0.86 ...

The global vaccine storage equipment market, valued at US$0.82 billion in 2023, is forecasted to grow at a robust CAGR of 7.2%, reaching US$0.86 billion in 2024 and an impressive US$1.21 billion by ...

Thermo Fisher (TMO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Thermo Fisher Scientific Inc. TMO is slated to release fourth-quarter 2024 results on Jan. 30, before market open. See the ...

Thermo Fisher Scientific (NYSE:TMO – Get Free Report) will likely be issuing its quarterly earnings data before the market ...

Advanced technologies like XRF, OES, and PAT optimize steel production by improving raw material usage, process efficiency, and recycling. Read how ...

Wedge Capital Management L L P NC grew its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by ...